Women Face Higher Risk for Severe AEs From Cancer Therapy

WEDNESDAY, Feb. 23, 2022 -- Women are at higher risk than men for severe cancer treatment-related adverse events (AEs), particularly for immunotherapy, according to a study published online Feb. 4 in the Journal of Clinical Oncology. Joseph M....
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news